PURPOSE: Although numerous publications have described distraction osteogenesis (DO) for craniosynostosis, methods of reporting quantitative results have been inconsistent. Therefore, the efficacy of anterior DO and posterior DO in regards to volume change is not well established. We report a metric that relates volume change to distraction length and our analysis of ICV change by distraction osteogenesis.
METHODS:
Patients with craniosynostosis were treated with open cranial vault reconstruction combined with internal distraction. Preoperative and postoperative CT scans were used to quantify ICV change. Our metric was calculated by dividing percent ICV change by total distraction length. Multiple linear regression was used to identify the impact of distraction approach (anterior vs. posterior), age, time between CT scans, distraction length, and preoperative volume on ICV change. Additionally, we compared our findings to those reported in the literature.
RESULTS:
Nine unicoronal craniosynostosis patients underwent anterior distraction. Three bicoronal patients and 1 multisutural patient underwent posterior distraction. The average ICV increase was 1.6% per millimeter of distraction for anterior DO compared to 4.2% for posterior DO (p<0.05). On multiple regression, preoperative volume was negatively associated with percent volume change (p<0.05). Posterior approach was positively associated with percent volume change (p<0.05). The volume-length relations from institutional data were greater than those derived from the literature, but not statistically significant.
CONCLUSION:
We report relations between distraction length and intracranial volume change for posterior and anterior DO and a comparison to the literature. Additionally, we describe a novel metric for analyzing ICV change achieved by DO. PURPOSE: Enhanced Recovery After Surgery pathway (ERAS) was introduced in 1997 as a multimodal approach to improve postoperative preventable harm and to shorten hospital length of stay (LOS). However, there is yet no widely accepted ERAS for microsurgical breast reconstruction (MBR). This study aims to conduct a systematic review and a meta-analysis of the current literature on ERAS for MBR in regards to postoperative LOS and morbidity.
19.

ENHANCED RECOVERY AFTER
METHODS:
We searched PubMed, Embase, Cochrane, Scopus and Web of Science for all studies published prior to June 2016 that contain original data investigating ERAS in MBR in relation to postoperative LOS and morbidity. Studies found were screened using eligibility criteria previously agreed upon. Meta-analysis, odds ratio and 95% confidence interval were used to pool acquired data.
RESULTS:
The initial search identified 87 studies. Two independent screeners identified four original articles, with a pooled population of 676 patients. ERAS LOS was reported in three studies to be lower when compared to the previous protocols, from 6.6 to 3.9 days (p<0.001), 7.4 to 6.2 days (p<0.001), and 6.2 to 3.1 days (p<0.001).Two studies were pooled for the meta-analysis of postoperative morbidity, which suggested that ERAS was not associated with changes in 30 days postoperative morbidity; partial flap loss (p=0.44), total flap loss (p=0.91), breast hematoma (p=0.69), donor site infection (p=0.53), urinary tract infection (p=0.29), and pneumonia (p=0.42).
CONCLUSION:
Our review suggests that ERAS in MBR is associated with lower LOS. The meta-analysis suggests that ERAS is not associated with increased postoperative morbidity. 
TOURNIQUET VS. EPINEPHRINE IN WIDE-AWAKE CARPAL TUNNEL RELEASE
PURPOSE:
Carpal tunnel syndrome is a common cause of upper extremity discomfort. Surgical release of the median nerve can be performed under general or local anesthetic, with or without a tourniquet. Wide-awake carpal tunnel release (CTR) (local anesthesia, no sedation) is gaining popularity. Tourniquet discomfort is a reported downside. This study reviews outcomes in wide-awake CTR and compares tourniquet versus no tourniquet use.
METHODS: Wide-awake, open CTR's performed from
February 2013-April 2016 were retrospectively reviewed. Patients were divided into two cohorts: with and without tourniquet. Demographics, comorbidities, tobacco use, operative time, estimated blood loss, complications and outcomes were compared. Statistical analysis was performed.
RESULTS:
A total of 304 CTR's were performed on 246 patients. The majority of patients were male (88.5%) and the mean age was 59.9 years. One hundred patients (32.9%) were diabetic and 92 patients (30.2%) were anticoagulated. Seventy five patients (24.7%) were smokers. A forearm tourniquet was used for 90 CTR's (29.6%). Mean operative time was 24.97 minutes with a tourniquet and 21.69 minutes without (p=0.0029). Estimated blood loss was 3.16mL with a tourniquet and 4.25mL without (p=0.0004). All other analyzed outcomes were not statistically significant.
CONCLUSION:
Operative time was statistically longer and EBL was statistically less with tourniquet use but these findings are not clinically significant. This suggests that local anesthetic with epinephrine is a safe and effective alternative to tourniquet use in CTR. The overall rate of complications was low and there were no major differences in post-operative outcomes between groups. PURPOSE: Up to 17% of diagnostic test results are missed, lost or ignored -despite conventional fixes (constant barrage of electronic physician reminders and even threat of penalties). Naïvely, patients assume: 'No-News-is-Good-News'. These lapses can result in poor outcomes, complications and even death. In response, CMS-led Physician-QualityReporting-System (PQRS) Measure#265 emphasizes prevention. Our pilot study aims to improve timely review of results through a novel, but simple approach: increase patient-engagement.
WHEN NO NEWS IS BAD NEWS: IMPROVING DIAGNOSTIC TESTING COMMUNICATION THROUGH PATIENT ENGAGEMENT
METHODS:
Sixty-one plastic-surgical patients undergoing diagnostic-testing were included in this IRB-approved study. Two groups, Group-A (Patients with medical chart access through our EMR "MyChart", n=29); and Group-B (Controls, n=33) were included. Group-A was reminded (via written After-Visit-Summary {AVS} and MyChart messages) to ask about their test results at their next appointment. Controls were sent no reminders, mimicking the status-quo. At subsequent visits whether patients 'asked' or 'did not ask' about their results was recorded and analyzed (Fisher's-Exact-Test). Study participants were also surveyed on their preferences for reminder communication.
